Daniel Wilkinson
@DSWilkinsonPhD
Followers
35
Following
64
Media
0
Statuses
5
Postdoc in the Fecci Lab by day…and also by night. Developing novel T cell-based therapeutics for GBM as a part of the Duke Brain Tumor Immunotherapy Program.
Joined May 2022
Honored and excited to have work from our group and led by @EmilyCLerner included in this collection!
✨In our #2023InReview special we provide a collection of 12 research highlights summarizing impactful papers published in 2023 and present a collection of some of our most striking @NatureCancer publications. Check them out for some end-of-year reading. https://t.co/6uhjoH90kG
0
0
4
📣 Check out our latest episode! Dr. @PeterFecci from @DukeMets talks about activating #Tcells to target brain tumors and his team’s work on targeting MHC-I-negative tumor cells. Listen now: https://t.co/XmO4BowUkh
0
2
7
Really interesting and exciting stuff!
Lerner and Woroniecka et al. showed that CD8+ T cell-dependent immunotherapies remain effective against β2m-lacking tumor cells, independent of NK cells, via CD8+ T cell-mediated cytotoxicity [...] https://t.co/XKov0jYJcL @EmilyCLerner @DukeMedSchool
0
1
2
Extraordinary clinical responses to CAR T cell therapy for solid tumors (heavily pretreated neuroblastoma) published in @NEJM from investigators in Italy! https://t.co/KqZKLx6LVp
nejm.org
Immunotherapy with chimeric antigen receptor (CAR)–expressing T cells that target the disialoganglioside GD2 expressed on tumor cells may be a therapeutic option for patients with high-risk neurobl...
2
9
35
Adaptive meets innate: CD8+ T cells kill MHC-I-negative tumour cells
3
32
89